Chromocell Therapeutics Corporation (CHRO)

USD 0.59

(-4.76%)

Gross Profit Summary of Chromocell Therapeutics Corporation

  • Chromocell Therapeutics Corporation's latest annual gross profit in 2023 was -2.57 Million USD , down -558.47% from previous year.
  • Chromocell Therapeutics Corporation's latest quarterly gross profit in 2024 Q2 was -12.96 USD , up 100.0% from previous quarter.
  • Chromocell Therapeutics Corporation reported a annual gross profit of -391.73 Thousand USD in annual gross profit 2022, down -87.39% from previous year.
  • Chromocell Therapeutics Corporation reported a annual gross profit of -209.04 Thousand USD in annual gross profit 2021, down -440.75% from previous year.
  • Chromocell Therapeutics Corporation reported a quarterly gross profit of -466.6 Thousand USD for 2024 Q1, up 81.91% from previous quarter.
  • Chromocell Therapeutics Corporation reported a quarterly gross profit of - USD for 2023 Q3, up 100.0% from previous quarter.

Annual Gross Profit Chart of Chromocell Therapeutics Corporation (2023 - 2020)

Historical Annual Gross Profit of Chromocell Therapeutics Corporation (2023 - 2020)

Year Gross Profit Gross Profit Growth
2023 -2.57 Million USD -558.47%
2022 -391.73 Thousand USD -87.39%
2021 -209.04 Thousand USD -440.75%
2020 61.34 Thousand USD 0.0%

Peer Gross Profit Comparison of Chromocell Therapeutics Corporation

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 1712.136%
Ampio Pharmaceuticals, Inc. -250 Thousand USD -931.767%
Armata Pharmaceuticals, Inc. -29.24 Million USD 91.179%
Actinium Pharmaceuticals, Inc. -709 Thousand USD -263.811%
Azitra, Inc. 260.45 Thousand USD 1090.366%
Can-Fite BioPharma Ltd. 743 Thousand USD 447.163%
Calidi Biotherapeutics, Inc. -1.25 Million USD -105.368%
CEL-SCI Corporation -3.95 Million USD 34.836%
iBio, Inc. -1.02 Million USD -151.651%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 131.175%
MAIA Biotechnology, Inc. - USD Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 80.741%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -2062.218%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 132.672%
NanoViricides, Inc. -759.01 Thousand USD -239.838%
Oragenics, Inc. -15.45 Million USD 83.308%
BiomX Inc. -1.22 Million USD -110.05%
BiomX Inc. -1.22 Million USD -110.05%
Protalix BioTherapeutics, Inc. 42.51 Million USD 106.068%
Palatin Technologies, Inc. 4.39 Million USD 158.724%
Scorpius Holdings, Inc. -2.21 Million USD -16.378%